# Acular LS vs. Nevanac in Post op Inflammation Following Cataract Surgery

> **NCT00348582** · PHASE4 · COMPLETED · sponsor: **Innovative Medical**

## Conditions studied

- Cataract

## Interventions

- **DRUG:** Ketorolac, Nepafenac

## Key facts

- **NCT ID:** NCT00348582
- **Lead sponsor:** Innovative Medical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2007-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00348582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00348582, "Acular LS vs. Nevanac in Post op Inflammation Following Cataract Surgery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00348582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*